Jane Street Group, LLC Viridian Therapeutics, Inc.\De Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	BUY	$14.5 - $21.61 $26,100 - $38,898	1,800 Added 14.75%	14,000 $301,000
Q2 2025 Aug 14, 2025	SELL	$11.02 - $16.09 $39,672 - $57,924	-3,600 Reduced 22.78%	12,200 $170,000
Q1 2025 May 14, 2025	BUY	$13.48 - $20.91 $212,984 - $330,378	15,800 New	15,800 $212,000
Q3 2024 Nov 14, 2024	BUY	$12.16 - $23.33 $181,184 - $347,617	14,900 New	14,900 $338,000

184

81.6M

39.6K

94.3K

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $1.15B
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.